Protherics PLC
6 monthly Block Listing Return
Approved Share Option Scheme
London, UK; Brentwood, TN; 9 October 2008 - Protherics PLC
("Protherics" or the "Company"), the international biopharmaceutical
company focused on critical care and cancer, in accordance with Listing
Rule 3.5.6, notifies the following details in respect of the block
listing for its Approved Share Option Scheme:
Name of applicant: Protherics PLC
Name of scheme: Protherics PLC Approved
Executive Share Option Scheme
Period of return: From: 9 April 2008 To: 8 October 2008
Balance of unallotted securities under 294,838
scheme at beginning of period:
The amount by which the block scheme Nil
has been increased during the period:
Number of securities issued/allotted 19,070
under scheme during period:
Balance under scheme not yet issued/ 275,768
allotted at end of period
/ Ends /
For further information please contact:
Protherics
Nick Staples, Director of Corporate Affairs +44 (0) 7919 480510
Julie Vickers, Company Secretary +44 (0)1928 518010
Financial Dynamics - press enquiries
London: Ben Atwell, Lara Mott +44 (0) 20 7831 3113
New York: John Capodanno +1 212 850 5600
Or visit www.protherics.com
This information is provided by RNS
The company news service from the London Stock Exchange
END
Contact Information: Contacts: RNS Customer Services 0044-207797-4400 http://www.rns.com